MX2020003976A - Procesamiento mecanico de biopolimeros. - Google Patents

Procesamiento mecanico de biopolimeros.

Info

Publication number
MX2020003976A
MX2020003976A MX2020003976A MX2020003976A MX2020003976A MX 2020003976 A MX2020003976 A MX 2020003976A MX 2020003976 A MX2020003976 A MX 2020003976A MX 2020003976 A MX2020003976 A MX 2020003976A MX 2020003976 A MX2020003976 A MX 2020003976A
Authority
MX
Mexico
Prior art keywords
biopolymers
mechanical processing
applications
processing methods
generally refer
Prior art date
Application number
MX2020003976A
Other languages
English (en)
Inventor
Richard Dolph Andersen
Annette Assogba-Zandt
Tina Lai
Isa Lietzau
Elena Maltseva
Andreas Voigt
Original Assignee
Solyplus Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solyplus Gmbh filed Critical Solyplus Gmbh
Publication of MX2020003976A publication Critical patent/MX2020003976A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof

Abstract

Las modalidades descritas en el presente documento generalmente se refieren a métodos de procesamiento de biopolímeros y aplicaciones que utilizan estos biopolímeros.
MX2020003976A 2017-10-12 2018-10-09 Procesamiento mecanico de biopolimeros. MX2020003976A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102017009799 2017-10-12
PCT/IB2018/057788 WO2019073361A1 (en) 2017-10-12 2018-10-09 MECHANICAL TREATMENT OF BIOPOLYMERS

Publications (1)

Publication Number Publication Date
MX2020003976A true MX2020003976A (es) 2020-10-01

Family

ID=63858002

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020003976A MX2020003976A (es) 2017-10-12 2018-10-09 Procesamiento mecanico de biopolimeros.

Country Status (7)

Country Link
US (1) US20200316208A1 (es)
EP (1) EP3675822A1 (es)
JP (1) JP7206281B2 (es)
BR (1) BR112020006620A2 (es)
CA (1) CA3077631A1 (es)
MX (1) MX2020003976A (es)
WO (1) WO2019073361A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021209493A2 (en) 2020-04-15 2021-10-21 Solyplus Gmbh Means and methods of preventing and treating infections
EP4267148A1 (en) 2020-12-22 2023-11-01 SolyPlus GmbH Means and methods of preventing, treating and detecting infections

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9902412D0 (en) * 1999-02-03 1999-03-24 Fermentech Med Ltd Process
TWI251596B (en) * 2002-12-31 2006-03-21 Ind Tech Res Inst Method for producing a double-crosslinked hyaluronate material
US8124120B2 (en) * 2003-12-22 2012-02-28 Anika Therapeutics, Inc. Crosslinked hyaluronic acid compositions for tissue augmentation
US9474715B2 (en) * 2011-11-30 2016-10-25 Andreas Voigt Polymeric drug-delivery material, method for manufacturing thereof and method for delivery of a drug-delivery composition
CN102772407B (zh) * 2012-08-01 2014-09-17 岳茂兴 一种促进神经损伤修复的药物组合物及其应用
EP3016634A2 (en) * 2013-07-05 2016-05-11 Therakine Biodelivery GmbH Drug-delivery composition for topical applications and injections and ophtalmic formulations, method for manufacturing thereof, and methods for delivery a drug-delivery composition
KR101513812B1 (ko) * 2013-11-22 2015-04-20 가천대학교 산학협력단 소수성 약물 전달용 마이크로 구조체의 제조방법
CN103768005B (zh) * 2013-12-31 2016-10-05 哈尔滨欧替药业有限公司 酮康唑阴道膨胀栓及其制备方法和检测方法
WO2016057607A1 (en) * 2014-10-08 2016-04-14 Therakine Micronized hydrophilic cross-linked biopolymer systems and method of making same
EP3263142A4 (en) * 2015-02-27 2018-10-24 Dainichiseika Color & Chemicals Mfg. Co., Ltd. Medical/cosmetic material and adhesion preventing material
CN106337208A (zh) * 2015-07-10 2017-01-18 湖北金环股份有限公司 一种化纤生产用甲壳胺浆粥的生产方法
CN105687227A (zh) * 2016-01-29 2016-06-22 江苏省苏北人民医院 一种口腔粘膜溃疡贴及其制备方法
CN106008118A (zh) * 2016-05-17 2016-10-12 深圳市芭田生态工程股份有限公司 一种果树种植多功能缓释复合肥料及其制备方法

Also Published As

Publication number Publication date
JP7206281B2 (ja) 2023-01-17
CA3077631A1 (en) 2019-04-18
WO2019073361A1 (en) 2019-04-18
BR112020006620A2 (pt) 2020-12-08
US20200316208A1 (en) 2020-10-08
JP2020536975A (ja) 2020-12-17
EP3675822A1 (en) 2020-07-08

Similar Documents

Publication Publication Date Title
CY1124663T1 (el) Αντιιικα παραγωγα ν4-υδροξυκυτιδινης
CY1121750T1 (el) Cot διαμορφωτες και μεθοδοι χρησης αυτων
ECSP18008905A (es) Tricíclicos sustituidos y método para usarlos.
CO2017013443A2 (es) Composiciones que comprenden cepas bacterianas del género blautia
BR112016028045A8 (pt) biopolímeros modificados, e seus métodos de produção
ECSP15048555A (es) Heterociclos bicíclicos como inhibidores de fgfr
TWD170354S (zh) 項鍊
TWD170595S (zh) 項鍊
BR112016019920A8 (pt) dispositivo médico implantável
CL2018000070A1 (es) Modulares de diaciglicerol aciltransderasa 2 (dgta2)
NI201400012S (es) Terminal portatil de información
BR112018017091A2 (pt) profármacos de pth
BR112017016562A2 (pt) métodos de produção de composições líquidas
CR20170005A (es) Derivados de insoindolina
BR112017016720A2 (pt) composição biodegradável resistente à umidade
AU359842S (en) Housing for light
ECSDI17052034S (es) Cantimplora
MX2020003976A (es) Procesamiento mecanico de biopolimeros.
CL2018001129A1 (es) Parche adhesivo con huecos
CL2017000645A1 (es) Síntesis de ent-progesterona e intermediarios de la misma
CL2020000586A1 (es) Moduladores de la expresión de enac.
CO2019005180A2 (es) Composición que contiene alulosa para promover la excreción de lípidos vegetales del cuerpo
ECSDI18002267S (es) Mandolina
NI201400126S (es) Dispositivo de transferencia
ES1205886Y (es) Tramado que maximiza la produccion en el cultivo de mitilidos

Legal Events

Date Code Title Description
HC Change of company name or juridical status

Owner name: LAC2BIOME S.R.L.